Essential function of the built-in lid in the allosteric regulation of eukaryotic and archaeal chaperonins

Department of Molecular and Cellular Physiology, Stanford University, Palo Alto, California, United States
Nature Structural & Molecular Biology (Impact Factor: 11.63). 06/2007; 14(5):432-40. DOI: 10.1038/nsmb1236
Source: PubMed

ABSTRACT Chaperonins are allosteric double-ring ATPases that mediate cellular protein folding. ATP binding and hydrolysis control opening and closing of the central chaperonin chamber, which transiently provides a protected environment for protein folding. During evolution, two strategies to close the chaperonin chamber have emerged. Archaeal and eukaryotic group II chaperonins contain a built-in lid, whereas bacterial chaperonins use a ring-shaped cofactor as a detachable lid. Here we show that the built-in lid is an allosteric regulator of group II chaperonins, which helps synchronize the subunits within one ring and, to our surprise, also influences inter-ring communication. The lid is dispensable for substrate binding and ATP hydrolysis, but is required for productive substrate folding. These regulatory functions of the lid may serve to allow the symmetrical chaperonins to function as 'two-stroke' motors and may also provide a timer for substrate encapsulation within the closed chamber.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The eukaryotic chaperonin TRiC (also called CCT) is the obligate chaperone for many essential proteins. TRiC is hetero-oligomeric, comprising two stacked rings of eight different subunits each. Subunit diversification from simpler archaeal chaperonins appears linked to proteome expansion. Here, we integrate structural, biophysical, and modeling approaches to identify the hitherto unknown substrate-binding site in TRiC and uncover the basis of substrate recognition. NMR and modeling provided a structural model of a chaperonin-substrate complex. Mutagenesis and crosslinking-mass spectrometry validated the identified substrate-binding interface and demonstrate that TRiC contacts full-length substrates combinatorially in a subunit-specific manner. The binding site of each subunit has a distinct, evolutionarily conserved pattern of polar and hydrophobic residues specifying recognition of discrete substrate motifs. The combinatorial recognition of polypeptides broadens the specificity of TRiC and may direct the topology of bound polypeptides along a productive folding trajectory, contributing to TRiC's unique ability to fold obligate substrates.
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Four families of heat shock proteins (Hsps), including the small heat shock proteins (sHsps), Hsp70, Hsp90 and Hsp60, are synthesized under normal physiological conditions and in response to stress. sHsps protect proteins from irreversible denaturation independently of ATP. The remaining ATP-responsive Hsps fold nascent proteins, shield proteins from irreversible denaturation during stress and aid protein refolding. Several observations indicate that Hsps contribute to disease resistance in aquatic organisms, the first being that these proteins are produced in finfish, shellfish and bivalves upon infection with viral and bacterial pathogens. Induction of Hsp synthesis by heat shock and incubation with chemicals such as Pro-Tex® boosts resistance to pathogens, as does administration of exogenous Hsps to host organisms. The extent of Hsp accumulation and the increase in disease tolerance are generally correlated with one another. Not only do Hsps protect against pathogens by functioning as molecular chaperones, but they are thought to mediate humoral and cellular innate immune responses. Hsp70 is highly immunogenic and serves as a ligand for Toll-like receptors. Hsps elicit cytokine production and they deliver peptides to antigen presenting cells via major histocompatibility complexes (MHC). Vaccines have been produced for use in aquaculture by employing Hsps, either alone or fused to antigens obtained from pathogens. Hsps offer several advantages over current methods for the treatment of disease in commercially important organisms and they are being increasingly exploited as their roles in protein chaperoning and immune modulation are better understood.
    11/2011; S2(S2):006. DOI:10.4172/2155-9546.